This initiative funds translational research to better understand the emergence and trajectory of schizophrenia and related disorders in individuals over 35 years old. It supports studies aimed at identifying targets for future prevention and treatment efforts, with clinical trials being optional. The focus is on advancing knowledge of these disorders during mid to late life stages.
Eligible applicants include a wide range of organizations such as state and local governments, tribal organizations, nonprofits, institutions of higher education, small businesses, and other specified entities including federal agencies and non-U.S. entities.
